Milestone Scientific Inc. financial data

Symbol
MLSS on NYSE
Location
220 South Orange Avenue, Livingston, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 198 % -35.3%
Quick Ratio 93.6 % +6.69%
Debt-to-equity 119 % +139%
Return On Equity -134 % -120%
Return On Assets -75.3 % -87.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.6M shares +0.95%
Common Stock, Shares, Outstanding 78.6M shares +1.14%
Entity Public Float 58.2M USD +45.4%
Common Stock, Value, Issued 78.6K USD +1.14%
Weighted Average Number of Shares Outstanding, Basic 82.3M shares +2.95%
Weighted Average Number of Shares Outstanding, Diluted 82.3M shares +2.95%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 655K USD -20%
Operating Income (Loss) -6.66M USD +0.52%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.67M USD -43.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -6.67M USD -44.4%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted -0.01 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.35M USD -71.8%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 475K USD +52%
Inventory, Net 4.13M USD +11.2%
Assets, Current 8.11M USD -24.2%
Property, Plant and Equipment, Net 18.3K USD +62%
Operating Lease, Right-of-Use Asset 178K USD -37%
Intangible Assets, Net (Excluding Goodwill) 96K USD
Other Assets, Noncurrent 24.2K USD 0%
Assets 8.49M USD -24.1%
Accrued Liabilities, Current 1.39M USD +29.8%
Liabilities, Current 5.03M USD +33.9%
Operating Lease, Liability, Noncurrent 68.9K USD -64.8%
Liabilities 5.94M USD +50.2%
Retained Earnings (Accumulated Deficit) -133M USD -5.29%
Stockholders' Equity Attributable to Parent 2.55M USD -64.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.34M USD -58%
Liabilities and Equity 8.49M USD -24.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.01M USD +17.2%
Net Cash Provided by (Used in) Financing Activities -2.28K USD -101%
Net Cash Provided by (Used in) Investing Activities -1.3K USD -100%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 78.6M shares +1.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.01M USD -198%
Deferred Tax Assets, Valuation Allowance 17.7M USD -19.7%
Deferred Tax Assets, Gross 17.7M USD -19.7%
Operating Lease, Liability 282K USD -26.8%
Depreciation 1.99K USD -0.8%
Payments to Acquire Property, Plant, and Equipment 1.19K USD
Lessee, Operating Lease, Liability, to be Paid 311K USD -30%
Operating Lease, Liability, Current 127K USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 139K USD +2.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 136K USD +2.08%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29.1K USD -50.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 35.5K USD -74.5%
Deferred Tax Assets, Operating Loss Carryforwards 15.4M USD -22.6%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Operating Lease, Payments 128K USD +2.78%
Amortization of Intangible Assets 17.5K USD +80.3%
Depreciation, Depletion and Amortization 40.9K USD -35.6%
Share-based Payment Arrangement, Expense 160K USD -23.1%